Aurobindo Pharma Ltd - Company overview

Tergene Biotech is a listed public limited company, first registered with ROC Hyderabad on 26 December 1986.

1986-12-26 Hyderabad, Telangana Active Listed Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹1000+ Cr
▲ 9.4%
FY 2025
PROFIT / LOSS
₹1000+ Cr
▲ 9.9%
FY 2025
EBITDA
₹1000+ Cr
▲ 23.3%
FY 2025
NET WORTH
₹1000+ Cr
▲ 9.4%
FY 2025
TOTAL ASSETS
₹1000+ Cr
▲ 10.5%
FY 2025
EMPLOYEE COUNT
10,000+
OPEN CHARGES
1
-
PAID-UP CAPITAL
57.54 cr
AUTHORISED CAPITAL
666.40 cr
COMPANY AGE
39 Years 10 Months
since 1986-12-26
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-10
ACTIVE GST
23
Updated: 2025-04-03 17:18:32
TOTAL MONEY RAISED
₹100–500 Cr
SATISFIED CHARGES
43
4,387.54 cr

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Tergene Biotech covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
75/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (38), financial health (95), director (90) and company-foundation signals.
  • Operating for 39+ years.
Compliance Score High risk
38/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
95/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2025.
  • Positive net worth.
Director Risk Score Low risk
90/100
Board strength, DIN status and churn.
  • 15 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Tergene Biotech Company identity, industry, contact, and registration details from MCA and company records.

Tergene Biotech is a listed public limited company, first registered with ROC Hyderabad on 26 December 1986. Its registered office is at Plot No.2, Maithrivihar, Behind Maithri Vanam, Ameerpet, Hyderabad, Telangana. It was earlier known as Aurobindo Pharma Pvt Ltd.

Its filings describe the main line of business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has 15 directors: Adi Reddy Baddigam, Santanu Mukherjee, Nityananda Reddy Kambam and 12 others. The longest-serving is Nityananda Reddy Kambam, on the board since 1992; the most recent to join is Punita Kumar Sinha, appointed in February 2026. Nityananda Reddy Kambam is the managing director. 21 former directors are on record; the most recent to leave was Deepali Pant Rajeev Joshi in March 2024.

Paid-up capital is ₹57.54 crore against an authorised ₹666 crore, so most of the authorised capital has not been issued yet. The last AGM on record was on 10 September 2025, for accounts made up to 31 March 2025. One charge (secured loan) is still open, and 43 more have been paid off. Its shares trade on BSE (524804) and NSE (AUROPHARMA).

Pharma ••••••••
  • Location Plot No.2, Maithrivihar, Behind Maithri Vanam, Ameerpet,, Hyderabad, Telangana - 500038
  • Website aurobindo.com
Name History
Legal NameAurobindo Pharma Ltd
CIN / LLPINL24239TG1986PLC015190
Company No.015190
Stock Symbol BSE: 524804 | NSE: AUROPHARMA
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date1986-12-26
Date of AGM2025-09-10
Date of Balance Sheet2025-03-31
Listing StatusListed
ROC CodeRoc Hyderabad
Credit RatingAA+ (Indiarating)
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Tergene Biotech (15) Current board members from MCA filings, including designation and appointment details.

A
Company Secretary | Since 2016-06-01 | DIN: 07341689
S
Director | Since 2023-02-09 | DIN: 07716452
N
Managing Director | Since 1992-12-30 | DIN: 01284195
M
Whole-time director | Since 2013-01-01 | DIN: 01284266
V
Director | Since 1992-12-30 | DIN: 01284132
S
Director | Since 2023-11-09 | DIN: 09377266

Financial Performance of Tergene Biotech Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2025
Revenue ₹1000+ Cr ▲ 9.4%
P&L ₹1000+ Cr ▲ 9.9%
EBITDA ₹1000+ Cr ▲ 23.3%
Net worth ₹1000+ Cr ▲ 9.4%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Tergene Biotech Open and satisfied charges registered against the company with MCA.

Ifci Limited : 511.00 cr
Dbs Bank Ltd : 164.00 cr
Axis Bank Limited : 37.98 cr
Open Charges: 1 Satisfied Charges: 43
Open -
Satisfied 4,387.54 cr
LenderAmountStatus
Dbs Bank Ltd
Creation Date: 08 Jan 2013
164.00 cr Closed
Ifci Limited
Creation Date: 25 May 2012
156.00 cr Closed
Ifci Limited
Creation Date: 25 May 2012
130.00 cr Closed

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Financial Ratios of Tergene Biotech Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

11 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Tergene Biotech Ownership and contribution detail from filings. Full breakdown unlocks with your report.

9 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Tergene Biotech EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Tergene Biotech GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Tergene Biotech Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

2 regulatory flags on record

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Tergene Biotech MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Tergene Biotech Parent, subsidiary, and related group entities. Full ownership map unlocks with your report.

6 subsidiaries on record

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

Parent company Subsidiaries and ownership Associates and joint ventures Entity investments

Corporate group structure requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Tergene Biotech Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tergene Biotech Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Tergene Biotech?
MCA does not publish an "owner" field. Tergene Biotech is run by its directors, Adi Reddy Baddigam, Santanu Mukherjee, Nityananda Reddy Kambam and 12 others, with Nityananda Reddy Kambam as managing director. It is owned by its shareholders, and the promoter holding is in the shareholding pattern it files with the stock exchanges.
Who are the current board members and directors of Tergene Biotech?
Tergene Biotech has 15 current directors: Adi Reddy Baddigam (since June 2016), Santanu Mukherjee (since February 2023), Nityananda Reddy Kambam (since December 1992), Madan Mohan Reddy Mettu (since January 2013), Venkata Ramprasad Reddy Penaka (since December 1992) and Satakarni Makkapati (since November 2023), plus 9 more. Nityananda Reddy Kambam is the managing director.
What is CIN of Tergene Biotech?
The CIN of Tergene Biotech is L24239TG1986PLC015190. Reading it left to right: L means it is listed, 24239 is the industry code it registered under, TG is Telangana, 1986 is the year it was registered, PLC is the company type and 015190 is its registration number.
When was Tergene Biotech incorporated?
Tergene Biotech was incorporated on 26 December 1986 with ROC Hyderabad. That makes it more than 39 years old.
What is the registered address of Tergene Biotech?
The registered office on MCA records is Plot No.2, Maithrivihar, Behind Maithri Vanam, Ameerpet, Hyderabad, Telangana - 500038.
What is the current status of Tergene Biotech?
MCA shows Tergene Biotech as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Tergene Biotech?
You can post to its registered office at Plot No.2, Maithrivihar, Behind Maithri Vanam, Ameerpet, Hyderabad, Telangana - 500038 and use its website, https://aurobindo.com.
What industry or business activity is Tergene Biotech associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Tergene Biotech?
Paid-up capital is ₹57.54 crore and authorised capital is ₹666 crore, so about 9% of the authorised amount has been issued.
When did Tergene Biotech last file accounts and hold an AGM?
The last AGM on record was on 10 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Tergene Biotech?
One charge against Tergene Biotech is still open and 43 have been satisfied. Lenders named in the filings include Dbs Bank Ltd, Ifci Limited and Axis Bank Limited.
Have any directors left Tergene Biotech?
Yes, 21 former directors are on record. The most recent to leave were Deepali Pant Rajeev Joshi (March 2024), Sivakumaran Meenakshisunderam (August 2023) and Sitarama Mandavilli Murty (April 2021).
What is the turnover or revenue of Tergene Biotech?
Based on filed financial statements, the revenue of Tergene Biotech for FY 2025 was in the ₹1000+ Cr range. That is up 9.4% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Tergene Biotech?
For FY 2025, the net worth of Tergene Biotech was in the ₹1000+ Cr range.
How can I get the financial details of Tergene Biotech?
The latest accounts on record are for FY 2025. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Tergene Biotech?
The website on record for Tergene Biotech is https://aurobindo.com.
Which company owns aurobindo.com?
aurobindo.com is the website listed for Aurobindo Pharma Ltd in its company records.
Is Tergene Biotech registered with any stock exchange in India?
It is listed on both BSE (scrip code 524804) and NSE (symbol AUROPHARMA).
Tergene Biotech - is it listed or unlisted?
Tergene Biotech is a listed company, and its CIN starts with L.
What is the ROC code of Tergene Biotech?
Tergene Biotech is registered with ROC Hyderabad.
What is the company classification of Tergene Biotech?
MCA classifies Tergene Biotech as: Public Limited Indian Non-Government Company.
Does Tergene Biotech have subsidiaries?
Yes, 6 subsidiaries are on record for Tergene Biotech.
Does Tergene Biotech have GST registrations on file?
Yes, 23 active GST registrations are linked to Tergene Biotech, usually one per state it operates in.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.